AMANDA HACKEMACK: Open Payments
NPI 1942770235 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,123 in 172 payments from 25 companies in 2025. Trend: 2023 $3,119 · 2024 $2,908 · 2025 $3,123
Food & beverage: $3,085Education: $38
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $545 |
| AstraZeneca Pharmaceuticals LP | 13 | $477 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $305 |
| PFIZER INC. | 32 | $253 |
| Lilly USA, LLC | 10 | $189 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $167 |
| Novo Nordisk Inc | 11 | $164 |
| GlaxoSmithKline, LLC. | 12 | $158 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $114 |
Products named: VRAYLAR, TRINTELLIX, BREZTRI, NURTEC ODT, MOUNJARO, AIRSUPRA, CAPLYTA, JARDIANCE.
Industry payments across IN — which companies pay providers there.
